52 related articles for article (PubMed ID: 34032998)
41. Observational Research Using Propensity Scores.
Raghunathan K; Layton JB; Ohnuma T; Shaw AD
Adv Chronic Kidney Dis; 2016 Nov; 23(6):367-372. PubMed ID: 28115080
[TBL] [Abstract][Full Text] [Related]
42. Polypharmacy and potentially inappropriate medication use in geriatric oncology.
Sharma M; Loh KP; Nightingale G; Mohile SG; Holmes HM
J Geriatr Oncol; 2016 Sep; 7(5):346-53. PubMed ID: 27498305
[TBL] [Abstract][Full Text] [Related]
43. Late endocrine effects of childhood cancer.
Rose SR; Horne VE; Howell J; Lawson SA; Rutter MM; Trotman GE; Corathers SD
Nat Rev Endocrinol; 2016 Jun; 12(6):319-36. PubMed ID: 27032982
[TBL] [Abstract][Full Text] [Related]
44. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.
Kantor ED; Rehm CD; Haas JS; Chan AT; Giovannucci EL
JAMA; 2015 Nov; 314(17):1818-31. PubMed ID: 26529160
[TBL] [Abstract][Full Text] [Related]
45. Infertility in reproductive-age female cancer survivors.
Levine JM; Kelvin JF; Quinn GP; Gracia CR
Cancer; 2015 May; 121(10):1532-9. PubMed ID: 25649243
[TBL] [Abstract][Full Text] [Related]
46. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care?
Kent EE; Forsythe LP; Yabroff KR; Weaver KE; de Moor JS; Rodriguez JL; Rowland JH
Cancer; 2013 Oct; 119(20):3710-7. PubMed ID: 23907958
[TBL] [Abstract][Full Text] [Related]
47. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research.
Stuart EA; Lee BK; Leacy FP
J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S84-S90.e1. PubMed ID: 23849158
[TBL] [Abstract][Full Text] [Related]
48. "You're too young for this": adolescent and young adults' perspectives on cancer survivorship.
Kent EE; Parry C; Montoya MJ; Sender LS; Morris RA; Anton-Culver H
J Psychosoc Oncol; 2012; 30(2):260-79. PubMed ID: 22416959
[TBL] [Abstract][Full Text] [Related]
49. Insights into different results from different causal contrasts in the presence of effect-measure modification.
Stürmer T; Rothman KJ; Glynn RJ
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):698-709. PubMed ID: 16528796
[TBL] [Abstract][Full Text] [Related]
50. Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003-2014.
Hsu CD; Nichols HB; Lund JL
J Cancer Surviv; 2022 Jun; 16(3):659-666. PubMed ID: 34032998
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.
Goh I; Lai O; Chew L
Curr Oncol Rep; 2018 Mar; 20(5):38. PubMed ID: 29582192
[TBL] [Abstract][Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
